These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 8830165)
1. Multiple sclerosis: a review of existing therapy and future prospects. Khan OA J Pak Med Assoc; 1996 Jan; 46(1):20-4. PubMed ID: 8830165 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis]. Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740 [TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Wingerchuk DM; Carter JL Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in multiple sclerosis, Part 2. Becker CC; Gidal BE; Fleming JO Am J Health Syst Pharm; 1995 Oct; 52(19):2105-20; quiz 2132-4. PubMed ID: 8535945 [TBL] [Abstract][Full Text] [Related]
5. Choosing drug therapy for multiple sclerosis. An update. van Oosten BW; Truyen L; Barkhof F; Polman CH Drugs; 1998 Oct; 56(4):555-69. PubMed ID: 9806103 [TBL] [Abstract][Full Text] [Related]
6. Immunosuppressive treatment of multiple sclerosis. Carter JL; Rodriguez M Mayo Clin Proc; 1989 Jun; 64(6):664-9. PubMed ID: 2473360 [TBL] [Abstract][Full Text] [Related]
8. Immunotherapy in multiple sclerosis, Part 1. Becker CC; Gidal BE; Fleming JO Am J Health Syst Pharm; 1995 Sep; 52(18):1985-2000. PubMed ID: 8528866 [TBL] [Abstract][Full Text] [Related]
9. Therapy of relapsing multiple sclerosis. Treatment approaches for nonresponders. Cohen JA; Carter JL; Kinkel RP; Schwid SR J Neuroimmunol; 1999 Jul; 98(1):29-36. PubMed ID: 10426359 [TBL] [Abstract][Full Text] [Related]
10. Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects. Pender MP; Wolfe NP Intern Med J; 2002 Nov; 32(11):554-63. PubMed ID: 12412939 [TBL] [Abstract][Full Text] [Related]
11. Therapy of multiple sclerosis in children and adolescents. Tenembaum SN Clin Neurol Neurosurg; 2010 Sep; 112(7):633-40. PubMed ID: 20471159 [TBL] [Abstract][Full Text] [Related]
12. Medications used in the treatment of multiple sclerosis. Schapiro RT Phys Med Rehabil Clin N Am; 1999 May; 10(2):437-46, ix. PubMed ID: 10370939 [TBL] [Abstract][Full Text] [Related]
13. Interferons in multiple sclerosis. A review of the evidence. Panitch HS Drugs; 1992 Dec; 44(6):946-62. PubMed ID: 1282865 [TBL] [Abstract][Full Text] [Related]
14. Tumefactive demyelinating lesions: A comprehensive review. Algahtani H; Shirah B; Alassiri A Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436 [TBL] [Abstract][Full Text] [Related]
15. Management of worsening multiple sclerosis with mitoxantrone: a review. Fox EJ Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460 [TBL] [Abstract][Full Text] [Related]
16. Corticosteroids in the treatment of multiple sclerosis. Myhr KM; Mellgren SI Acta Neurol Scand Suppl; 2009; (189):73-80. PubMed ID: 19566504 [TBL] [Abstract][Full Text] [Related]
17. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]